Claude Maraoui, President and Chief Executive Officer of Journey Medical, commented, “Ramsey’s promotion to COO reflects his exceptional leadership and the critical role he has played in our Company’s ...

The layoffs are the latest indication of Health Secretary Robert F. Kennedy Jr.’s drastic effort to completely remake the nation’s public health infrastructure.

Cellares' forward momentum continues, as the company announced April 1, 2025, a notable milestone for its Cell Shuttle.

We are excited to welcome Steve to Phathom during this important growth period for our Company,” said Michael Cola, Chairman of Phathom. “Steve is an accomplished biopharmaceutical leader with a ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding Zepbound and Mounjaro. Compounding of tirzepatide, ...

Photobiomodulation Therapy (PBMT) uses red and near-infrared light to enhance cellular repair, reduce inflammation, and support neurological and skin health. Learn how it works, how it's different ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...

Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...